Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and array-based technologies, today announced a collaboration with Broad Clinical Labs to rapidly streamline and scale ...

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology: Basel Saturday, February 22, 2025, 11:00 Hrs [IST] Roche unveiled its pr ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

< Various diseases of the hematopoietic system are referred to as blood cancers. They can affect the b ... Colourbox ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...

Their findings, as their Science Advances study explains, points to a “complex epigenetic and genetic network” of ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

RAMP UP grants were awarded in total, with participants currently progressing through various stages of the consignment agreement process. Upon completion, participants will use the OhmX platform to ...

Does aspartame increase heart disease risk? A new study in mice suggests a link, but experts caution against jumping to ...